INTRODUCTION
============

RNA has a wonderful capacity to form complex, stable tertiary structures due to its conformational flexibility, modularity and versatility. This capacity enables RNA molecules to play essential roles in cellular processes of all organisms ([@b1]--[@b4]), mediated by ligand-binding, complementary base pairing and catalytic reactions. Recent discoveries have highlighted the regulatory roles of small functional RNA motifs in the control of gene expression. For example, riboswitches regulate translation via binding of mRNA to metabolites ([@b5]), and microRNAs suppress gene expression by complementary base pairing ([@b6]). Since ligand-binding and base pairing are fundamental aspects of RNA interactions and activities, many such small functional RNA motifs may exist inthe cell.

With rapidly growing interest in RNA structure and function, the central objective of increasing RNA\'s functional repertoire has led to various experimental and computational approaches. The current genome-wide searches for natural functional RNA molecules include genetic screening \[e.g. the FANTOM Consortium and the RIKEN group ([@b7],[@b8]) and others ([@b9]--[@b11])\], comparative genomics ([@b12],[@b13]), neural networks ([@b14]), graph theory ([@b15],[@b16]) and other complementary approaches ([@b17]). Unlike proteins, computational RNA genomics is still in its early stages of development, requiring new ideas and tools to advance the field.

Here, we develop and apply a method for finding small functional RNA motifs in genomic sequences based on synthetic functional motifs derived from *in vitro* selection experiments. *In vitro* selection is an iterative experimental process for uncovering small RNA molecules from a large pool of random sequences with a specific physical or chemical property ([@b18],[@b19]) \[reviewed in ([@b20])\]. Numerous target-binding nucleic acid molecules (known as 'aptamers') have been identified using this approach, with targeted molecules including organic molecules, antibiotics, peptides, proteins and whole viruses ([@b20],[@b21]). In addition, *in vitro* selection experiments have led to the discovery of novel RNA enzymes (ribozymes) and to many applications in biomolecular engineering, e.g. allosteric ribozymes and biosensors ([@b22]--[@b27]). Clearly, *in vitro* selection has many important applications in biology, chemistry, medicine and biotechnology ([@b22],[@b24]--[@b26],[@b28]--[@b30]).

Although *in vitro* selection typically generates artificial, non-biological molecules, Szostak\'s group ([@b31]) recently found that the evolution-mimicking process of *in vitro* selection can recreate biologically active RNA motifs known *in vivo*, such as the hammerhead ribozyme. Moreover, recent findings show that metabolite-induced RNA conformational changes (i.e. natural RNA aptamers) control bacterial gene expression ([@b5]). Interestingly, Piganeau and Schroeder, in response to the Patel group\'s structural characterization of the streptomycin-binding aptamer ([@b32]), commented that 'We can now predict that many biosynthetic pathways will be regulated by metabolite binding 'natural aptamers,' and we might even find a structure similar to the streptomycin aptamer in a bacterium producing streptomycin' ([@b33]). Thus, experimental studies suggest that *in vitro* selected motifs may exist *in vivo*, and these findings imply that synthetic functional motifs may be exploited for expanding the repertoire of natural functional RNAs. Natural RNA motifs similar to *synthetic* aptamers are likely to exist because aptamers bind to certain targets that are prevalent in Nature (e.g. streptomycin produced by bacteria, ATP, FMN).

Currently, the Aptamer Database ([@b34]) lists ∼300 aptamer and artificial ribozyme sequences spanning diverse functions. This valuable information provides a unique opportunity for uncovering many small natural functional motifs in genomes. Our method involves extracting critical topological and sequence-specific features of *in vitro* selected motifs, searching for potential genomic sequences that may exhibit similar properties when folded and screening of candidate sequences using thermodynamics criteria for structural stability to eliminate spurious matches. After applying the method to several aptamers that bind either ATP, chloramphenicol, neomycin B or streptomycin, we find 37 candidate sequences that fold to the target aptamer motifs distributed among 9 bacterial and 4 archaeal genomes. Of these, several exhibit energetic properties and sequence conservation patterns that are characteristic of functional motifs. More generally, our study suggests that such 'natural aptamers' may be abundant in the genomes of various organisms.

The advantage of this computational approach to finding novel functional RNA motifs is that the biological activity is known a priori. Thus, the method is not limited to the existing repertoire of natural RNAs since the *in vitro* selected functional motifs can be expanded as needed, allowing identification of truly novel motifs not accessible by other techniques. In the near future, combining our computational prediction algorithm with experimental verification techniques has the potential to evolve a functional RNA motif discovery approach complementary to existing experimental and computational techniques.

METHODS
=======

Overall approach
----------------

In brief, we extract the relevant structural and sequence information from *in vitro* selected aptamers that accounts for the molecule\'s functionality and search for genomic RNA sequences with the specified (sequence and structure) motif; we then assess the candidate sequences by performing thermodynamic stability and statistical significance tests which involve calculating heat-capacity curves, free energies, energy landscapes and expected motif occurrence frequency in random sequences. Although we develop the protocol to search for aptamers, it can be generalized to ribozyme motifs.

Our algorithm consists of four major steps: The motif descriptor is constructed manually by extracting the critical sequence and structural features from the *in vitro* selected functional RNA molecule that confer binding affinity (usually consensus sequences and secondary structures). If X-ray crystallography or NMR studies of aptamer motifs are available, detailed structural features are incorporated in the motif descriptor. Such studies help pinpoint important structural properties of the motif, including the overall qualitative structure (e.g. loops, bulges, hairpins, lengths of stems, etc.) and sequence information specifying critical hydrogen-bonding interactions (e.g. [Figure 1](#fig1){ref-type="fig"} for the streptomycin--aptamer complex).The genomes of selected organisms are searched using the RNAMotif program ([@b35]), a motif scanning tool, for the structure specified by the motif descriptor. The program searches for sequences in genomes that could potentially fold into the specified secondary structure based on base pairing rules (Watson--Crick, wobbles and non-canonical base pairs).The sequence hits are then folded using the Vienna RNA Package ([@b36]), a secondary structure prediction algorithm. Although the algorithm is imperfect (pseudoknots and magnesium ions are excluded), it is known to be reasonably accurate for the short sequences we study, \<100 nt. Genomic sequences that fold to the target motifs define our candidate natural aptamer motifs.The candidates are further subjected to statistical significance and thermodynamic stability tests to assess their quality and eliminate likely false-positives. The stability test involves assessing the candidates\' thermodynamic variables and energy landscapes in comparison with those for randomly shuffled sequences; the statistical significance test is established by calculating expected motif occurrence frequency in random sequences with a uniform base composition. These tests are described in detail below.

Aptamer motif descriptors
-------------------------

Creating motif descriptors requires biological intuition and experimentation. Generally, the results of many *in vitro* selection studies include a family of similar sequences with the desired function. Therefore, based on sequence conservation, it is possible to judge how much variability to allow in certain parts of the structure. This sequence conservation has been used by experimentalists to produce minimal (shorter), active aptamers binding antibiotic targets ([@b37],[@b38]). Our motif descriptors are designed for these aptamers, though they do not necessarily match the raw sequences from *in vitro* selection experiments. The motif descriptors for antibiotic and ATP-binding aptamers are shown in [Figure 2](#fig2){ref-type="fig"}, and their RNAMotif descriptor files are available in Supplementary Data.

### ATP-binding aptamers

All ATP-binding aptamers have a small, highly conserved consensus sequence embedded within a common secondary structure. The smallest secondary structure model for ATP aptamer was supported by deletion analysis as well as dimethylsulfate modification experiments ([@b38]). The structure model has a simple hairpin structure with an asymmetric bulge containing the consensus sequence (GGAAGAAACUG), which mediates the binding; the two helices surrounding the bulge are variable in length (we allow 6--14 bp). The constructed descriptor reflects exactly this information ([Figure 2a](#fig2){ref-type="fig"}); it also matches several *in vitro* selected ATP sequences in refs ([@b39],[@b40]).

### Chloramphenicol-binding aptamers

Several of the selected chloramphenicol aptamer sequences exhibit sequence conservation and the ability to fold into similar secondary structures. The secondary structure model is supported through deletion--selection analysis and RNase S~1~ sensitivity analysis ([@b41]). The structure is composed of a hairpin with two adenine-rich asymmetric bulges which are responsible for binding. The helix in between the two bulges is only slightly variable in length (4--6 bp), while the two outer helices allow higher variability.

### Neomycin B-binding aptamers

The neomycin B descriptor is a simple hairpin structure originally elucidated by footprinting experiments ([@b42],[@b43]). The common sequence feature is that the hairpin loop is composed of three G-U wobble pairs followed by a G-C pair right before the loop starts. The loop exhibits a consensus where the first nucleotide is a guanine and the rest of the loop is adenine-rich; the loop is closed off by a non-canonical A-G pair. NMR experiments elucidate how the RNA binds the neomycin B and verifies that the conserved sequences are actually critical for the binding to take place ([@b43]).

### Streptomycin-binding aptamers

The streptomycin-binding aptamer was also discovered as a motif with a consensus sequence in the bulges ([@b32],[@b37]). The raw sequences are ∼75 nt long whereas the corresponding minimally active structure is only ∼40 nt in length. The minimal structure is composed of two asymmetric bulges in a hairpin structure, with the middle helix relatively not variable in length, and the other two helices highly variable. The structure was initially elucidated using a variety of techniques, including probing though Pb^2+^-induced RNA cleavage, dimethylsulfate and kethoxal. Later, the structure of the RNA--streptomycin complex was solved by X-ray crystallography ([@b32]), allowing the identification of the specific nucleotides in the aptamer that confer binding specificity. Specifically, the experimental sequence for the 5′ asymmetric bulge is 5′-G6-C7-A8-U9-U10-U11-G12, but based on the information in [Figures 1](#fig1){ref-type="fig"} and [2d](#fig2){ref-type="fig"}, only the first nucleotide and the last 2 nt (G and UG respectively) are involved in the hydrogen-bonding network. Therefore, it is possible to search for the sequence motif GNANNUG in the asymmetric bulge.

Melting curve analysis of candidate sequences
---------------------------------------------

Biological molecules generally possess stable structures at physiological temperatures. The stability of RNA secondary structures with respect to temperature change can be analyzed using heat-capacity curves ('melting' curves). These curves represent the amount of energy absorbed per unit change in temperature at any given temperature (i.e. *dH/dT* versus *T*, where *H* is the RNA\'s conformational enthalpy). For each candidate sequence, we compute the melting curve using tools available in the Vienna RNA Package ([@b36]). Additionally, to discriminate random from probable functional RNA sequences, we randomly shuffle each candidate sequence 1000 times and compute the corresponding melting curves. The melting temperature, *T*~m~, is defined as the temperature at the highest peak; it may also be interpreted as the transition temperature at which the RNA molecule\'s secondary structure experiences significant disruption. For each sequence (the candidate and the randomly shuffled ones), we plot the melting temperature (*T*~m~) against the free energy ($\Delta G_{37}^{\text{o}}$) as a further indicator of stability. We then use principal component analysis to compute a 90% confidence ellipse to determine whether the original sequence is significantly more stable than its randomly shuffled sequences.

Conformational energy landscapes for candidate sequences
--------------------------------------------------------

Functional RNA molecules likely have a steeper conformational energy landscape compared with random sequences since they are expected to favor a native, intrinsic fold and must attain the native fold relatively fast ([@b44]). Thus, examination of the shape of the energy landscape offers an alternative approach for discriminating RNA-like from non-RNA-like molecules. The energy landscape is defined as a plot of RNA\'s internal energy (*E*) versus the base pair dissimilarity 'distance' (*D*) between the minimum energy structure and each suboptimal structure. More precisely, for a numbered sequence, *D* is defined as the number of dissimilarly numbered base pairs between two secondary structures ([@b36]). In practice, the suboptimal structures are calculated up to a given energy level (e.g. 5 kcal/mol above the minimum).

To characterize and quantify the conformational energy landscapes, we compute the 'Valley index,' described in ([@b45]), which provides a measure of the overall shape of the landscape (i.e. steepness and number of minima). The Valley index, *V*, is computed by forming the Boltzmann-weighted average of distances between all pairs of structures (minimum energy and suboptimal): $$V = \frac{\sum_{i,j}{w\left( i \right) \cdot D_{ij} \cdot w\left( j \right)}}{\sum_{i,j}{w\left( i \right) \cdot w\left( j \right)}}$$ with $$w\left( i \right) = \text{exp}\left\{ \frac{E_{\text{min}} - E_{i}}{k_{B}T} \right\}$$ where *D~ij~* is the base dissimilarity distance between structure *i* and structure *j*, and *E~i~* is the energy of structure *i*. Similar to the procedure for the melting curves, we randomly shuffle the candidate sequence 1000 times and plot the Valley index *V* versus the ensemble free energy $\Delta G_{37}^{\text{o}}$ and assess the relative stability of the target sequence using a 90% confidence ellipse.

Since the Valley index is a Boltzmann-weighted average of the distances between two structures, competing low-energy structures that are 'far' from each other (i.e. have highly distinct structures) will contribute significantly to the Valley index, giving it a large value. Functional RNA molecules are likely to have smaller Valley index values compared with random sequences since they are expected to favor a native, intrinsic fold.

Statistical analysis
--------------------

The theoretical frequency of observing a given motif in a random sequence of nucleotides can be estimated ([@b46]), allowing assessment of the statistical over or under-representation of the motif in the genome of a specific organism. Since the motif descriptors of aptamers allow for variability of length and sequence, analytic computation based on the motif\'s information content is complex ([@b46]--[@b48]). Thus applying a Monte Carlo method to calculate the frequency is appropriate.

We consider a 1 Mb random sequence of nucleotides (25% A, U, C, G) as a random vector **X** and define φ(**X**) as the number of times the given motif is found in **X**; we then estimate the expected value *E*\[φ(**X**)\] using a sample-mean method that, for each iteration, generates a 1 Mb uniformly distributed sequence of nucleotides \[using the Mersenne Twister algorithm ([@b49])\] and counts the number of times that the given motif is observed in the sequence (using RNAMotif). We average this number over one million iterations and estimate the standard error to define the number of hits a specific target motif can be expected to be found in a genome. The deviation from this estimate allows us to assess the significance of our actual findings.

Selected bacterial and archaeal genomes
---------------------------------------

We choose 10 bacterial and 16 archaeal species (\>100 complete genomes are available). Since the *Streptomyces* species produce many known antibiotics (including those used here), we use the two available *Streptomyces* genomes. Additionally, we choose *Escherichia coli* genomes since they are among the best characterized bacterial species. Other bacterial genomes were selected randomly. For the searches involving the ATP aptamer, we use 16 of the available archaeal genomes at the National Center for Biotechnology Information (<http://www.ncbi.nlm.nih.gov>).

Computational performance
-------------------------

The computational speed depends on both the genome size and the complexity of the descriptor. The searches using the RNAMotif program are very fast for bacterial-sized genomes (∼10 Mb): for the streptomycin-binding aptamer in [Figure 2d](#fig2){ref-type="fig"}, \<1 min is required for the largest genome searched (*Streptomyces avermitilis*, ∼9 Mb). Subsequently, the sequence hits are 'folded' using the RNAfold program. For a sequence \<100 nt, the predicted secondary structure is computed in several seconds.

The screening analyses (step iv) are more computationally intensive. Generating suboptimal structures for energy landscape assessment is relative efficient, taking only a few minutes for 200 000 structures. However, calculating heat-capacity curves can take several minutes. Since we generate 1000 curves for each sequence, the process can take up to several CPU hours. The computation of the theoretical expected frequency of each motif is most intensive since we perform on the order of one million iterations of the sample-mean method. The combined calculations (genome scanning, suboptimal structures and expected frequency) require several weeks of computation. All computations were performed on a SGI 300 MHz MIPS R12000 IP27 processor with 4 GB of memory.

RESULTS AND DISCUSSION
======================

We search for three aptamer motifs for the antibiotics chloramphenicol ([@b41]), streptomycin ([@b32],[@b37]) and neomycin B ([@b42],[@b43]) in bacterial genomes, as well as for an ATP-binding aptamer ([@b38]) in archaeal genomes. The four motif descriptors are shown in [Figure 2](#fig2){ref-type="fig"} (middle structure). [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"} summarize our initial search results from the RNAMotif program for sequence hits in bacterial and archaeal genomes matching the four aptamer target descriptors (without filtering by sequence folding and energetic analyses). There is a total of 46 (3 × 10 + 1 × 16) aptamer motif/genome pairs. To determine statistical significance, [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"} also report the expected number of motif matches for each genome computed from searches in random sequences ('Exp.'); thus, when the number of hits (under 'Obs.') is greater than the number of expected hits (under 'Exp.'), a potential significant finding may arise.

The filtering step, folding each sequence and discarding those that fold into structures that are not similar to the target experimental motif structure, reduces the number of sequence hits from 211 to 37, which define our candidate sequences ([Table 3](#tbl3){ref-type="table"}); for the streptomycin aptamer, only one candidate sequence remains. [Table 3](#tbl3){ref-type="table"} also reports results from thermodynamic tests of candidates.

Statistical analysis reveals over or under-representation of aptamer motifs in genomes
--------------------------------------------------------------------------------------

Knowing the over or under-representation of motifs in a given genome helps determine the biological significance of sequence hits. [Figure 3](#fig3){ref-type="fig"} plots the expected versus observed matches for all 46 motif/genome pairs in our study. The expected number of matches for a genome is calculated from the average number of matches per million base pairs for a sequence of random nucleotides ([Table 4](#tbl4){ref-type="table"}). As shown in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"} and [Figure 3](#fig3){ref-type="fig"}, the observed number of matches deviates from the expected number of matches for many motif/genome pairs. Significantly, most of the aptamer motif/genome pairs are over-represented, meaning that their occurrence frequencies in genomes cannot be accounted for by chance. For instance, as highlighted in [Figure 3](#fig3){ref-type="fig"}, the expected numbers of matches are considerably lower than the observed numbers of matches to the chloramphenicol (7 versus 1.8 expected matches) and neomycin B (∼16 versus 11 expected matches) aptamer motifs in *E.coli* genomes. In contrast, neomycin B and chloramphenicol aptamer motifs are under-represented in *Streptomyces*.

Specifically, the average number of matches to the neomycin B aptamer motif in *Streptomyces* genomes is 4, while the average number in *E.coli* is four times greater. Since the average *Streptomyces* genome size is almost twice that of the average *E.coli* genome (∼9 versus ∼5 Mb), these trends are significant because probability alone would predict the number of matches in *Streptomyces* genomes to be about twice as many matches as *E.coli*, not one-fourth as obtained. This might indicate a biological preference/discrimination for/against this aptamer, i.e. either *Streptomyces* is significantly missing this structure, or *E.coli* has a significantly large occurrence of it.

In general, the number of matches for the ATP motif in archaeal genomes shows that most genomes do not exhibit a significant number of matches over or under the expected number ([Table 2](#tbl2){ref-type="table"}). However, *Aeropyrum pernix*, *Archaeoglobus fulgidis DSM 4304*, *Methanobacterium thermoautotrophicum*, *Methanosarcina acetivorans C2A* and *Pyrococcus furiosus DSM 3638* all produce far more matches for the ATP aptamer than the expected number, even though their nucleotide compositions are uniformly distributed.

To estimate the expected number of sequence matches, we used random sequences with a uniform nucleotide composition \[i.e, the T(U):C:A:G should be 1:1:1:1\]. Judging by the nucleotide composition data in [Table 5](#tbl5){ref-type="table"}, most genomes are nearly uniformly distributed. If the nucleotide composition of a genome deviates significantly from uniform the expected number of matches should be calculated using random sequences with the same nucleotide composition. By using the biased nucleotide distribution of *Streptomyces* (30% A/T and 70% G/C), we do not find a significant deviation in the expected number of matches. Calculation of expected matches using complex random sequence models, such as higher-order Markov chains (dinucleotide, trinucleotide, etc. distributions), may also be considered to generate more accurate estimates ([@b46],[@b47],[@b50]) but are not expected to produce significant changes in the results.

Energetic analysis discriminates natural from random RNA sequences
------------------------------------------------------------------

With the significantly smaller pool of filtered sequences (following RNAfold), we now proceed to thermodynamic evaluation of the 37 candidates in [Table 3](#tbl3){ref-type="table"} using melting temperature ($T_{\text{m}} - \Delta G_{37}^{\text{o}}$ plot) and Valley index ($V - \Delta G_{37}^{\text{o}}$) tests. The $T_{m} - \Delta G_{37}^{\text{o}}$ scatter plot for a promising candidate sequence should have favorable energetic characteristics compared with randomized sequences. We analyze the scatter plots using an ellipse oriented along the principal component axes that contains 90% of the points. As a check of the $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ test, we applied it to five known biological RNAs. [Table 6](#tbl6){ref-type="table"} shows that all the biological sequences land outside the confidence ellipse; similar results are obtained for a dozen RNAs. A previous study using the free energy criterion alone did not yield sufficient discrimination for functional RNAs ([@b51]). The $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ plots for four candidate aptamer sequences (numbered 7/8, 17--20, 31 and 32 in [Table 3](#tbl3){ref-type="table"}) are shown in [Figure 4](#fig4){ref-type="fig"}. The candidate aptamer sequences for ATP (sequence 7/8 in *Halobacterium* sp.) and neomycin B (sequences 17--20, 31 and 32 in *E.coli*) lie outside this ellipse and away from the bulk of random sequences; as noted before, the neomycin B motif is over-represented in the *E.coli* genomes. We observe that the candidate aptamers have favorable energetic parameters even though they do not have the lowest free energies or highest melting temperatures compared with some randomized sequences.

Similarly, we analyze the conformational energy landscape and assess the corresponding $V - \Delta G_{37}^{\text{o}}$ plot for each candidate sequence. [Figure 5](#fig5){ref-type="fig"} shows the energy landscape plot for neomycin B candidate sequences 32 and 33/34 from *E.coli* and *Neisseria meningitidis*, respectively. The good candidate sequence 32 possesses a steep single-minimum landscape conformational energy landscape with a small *V* value of 1.44, whereas the poor candidate 33/34 has multiple low minima with *V* = 8.29. The Valley index, a quantitative measure of the conformational energy landscape, allows for a specific and rigorous quantitative test and accounts for the much higher-dimensional quality of the pair-wise distances between all suboptimal structures.

Similar to the $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ plots in [Figure 4](#fig4){ref-type="fig"}, we use 1000 randomized permutations and 90% confidence ellipse in $V - \Delta G_{37}^{\text{o}}$ plots to assess biological significance of candidate sequences. For biological sequences (5S, tRNA, U5, U6, U7), [Table 6](#tbl6){ref-type="table"} shows that 4/5 cases pass the Valley index test \[i.e. their sequences lie outside the 90% confidence ellipse ([@b45])\], suggesting that the $V - \Delta G_{37}^{\text{o}}$ test is reasonable. Applying the Valley index test to the 37 candidate aptamer sequences in [Table 3](#tbl3){ref-type="table"}, we find that candidate sequences 7/8, 31 and 32 pass the test. Thus, except for candidate 17/18/19/20, candidates that pass the melting temperature test also pass the Valley index test.

In [Table 3](#tbl3){ref-type="table"}, we retain all 37 correctly folded aptamer candidates, even though most do not pass the thermodynamic tests, because these tests are imperfect, especially for small RNA motifs. More importantly, most false-positive sequences are already eliminated by the folding step; for example, we observe that for tRNA \>95% of the false-positive tRNA sequences matching the tRNA motif are eliminated by the folding step.

The thermodynamic tests measure the specificity of the search algorithm. Also important is the algorithm\'s sensitivity, i.e. the success in detecting a known RNA class. We assess this sensitivity of our algorithm for *E.coli K12* tRNAs by using the tRNA motif descriptor in the RNAMotif package. The tRNA descriptor identifies 74 out of 86 known *E.coli K12* tRNAs, yielding a high success rate of 86%. Of the 74 tRNA sequences detected, only 33% (25 sequences) fold correctly to the tRNA shape by the RNAfold algorithm. Of the remaining 25, 17 pass the melting temperature test, yielding a success rate of 68%. Thus, for tRNA the overall sensitivity of our algorithm is ∼20%. Clearly, sensitivity depends on specific RNA classes, and the weak component of our overall protocol is the RNAfold folding application. If we were to extrapolate from the tRNA findings, the number of possible aptamer motifs in genomes might be five times the number of detected aptamer sequences.

The results of both the melting temperature and Valley index tests are summarized in [Table 3](#tbl3){ref-type="table"} for all 37 candidate sequences that are predicted to fold into target structures. Of these 37 matches, there are 21 distinct sequences (since many of the sequences occur in multiple organisms in multiple locations). The table shows that four of the sequences pass the $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ test (sequences 7/8, 17--20, 31 and 32), while only three of the sequences pass the $V - \Delta G_{37}^{\text{o}}$ test (sequences 7/8, 31 and 32). Taken together, we produce the promising candidates for experimental verification, i.e. binding of candidate motifs to antibiotics, as: 7/8, 17/18/19/20, 31 and 32. It is also possible that few sequences pass the tests because they are so short. Even some biological sequences may fail the energetic tests because functional properties might not be revealed by such tests; for example, many snoRNAs, which interact extensively with ribosomal RNAs via base pairing, do not pass such tests. Biological sequences are generally longer (more than 70 nt). This means that the predictive algorithms can characterize their properties better than short sequences, such as the ones in [Table 3](#tbl3){ref-type="table"}. Furthermore, in all tested cases, the Valley index test is more stringent than the melting temperature test.

The above 2D correlation analyses involving free energy, melting temperature and Valley index can be generalized to three or higher dimensions. For ellipsoidal confidence analysis, it can be shown that the confidence level increases as the dimensionality decreases. Thus, for a fixed confidence level, screening in higher dimensions is more stringent than that for lower dimensions. Currently, 1D thermodynamic screening criteria use either free energy or Valley index. We have used 2D analyses to improve on these screening criteria.

In addition to the above energetic tests, we also assess the stability of the candidate sequences within larger sequences for those candidates occurring in known genes (see [Table 3](#tbl3){ref-type="table"}). We fold the entire gene sequence with and without constraining the aptamer\'s structure to determine the change in the optimal free energy ($\Delta\Delta G_{37}^{\text{o}}$). The optimal energy of the constrained structure is always higher than that for its unconstrained structure. A significant limitation of this assessment is that RNA fold predictions are not accurate for long sequences (the gene sequences are ∼1000 nt). Still, we find that for candidate sequences 1, 2, 3, 25 and 26, the $\Delta\Delta G_{37}^{\text{o}}$ values are between −1 and 0 kcal/mol, indicating that these aptamer structures are likely stable within the larger sequence context. For candidate sequences 32 and 37, $\Delta\Delta G_{37}^{\text{o}}$ is −4 kcal/mol compared with aptamer energies of about −10 kcal/mol; for other candidate aptamers ([@b9]--[@b12],[@b17]--[@b24]) within genes, the $\Delta\Delta G_{37}^{\text{o}}$ values are comparable to their aptamer energies.

Yet another test of the candidate natural aptamers\' stability is to fold them within a slightly larger sequence context. We perform this test for all the four good candidates (sequences 7/8, 17--20, 31 and 32). Specifically, we extend these candidate sequences by 10 nt at the 3′ and 5′ ends and refold them. Encouragingly, the key motif elements (A-rich bulge of ATP aptamer and stem--loop motif of Neomycin B aptamer) of all the shorter (original) sequences responsible for binding are maintained, indicating their stability within the larger sequence context.

Sequence conservation and four promising candidate natural aptamer sequences
----------------------------------------------------------------------------

The physical and statistical analyses above helped us evaluate the candidate sequences that are most likely to have the properties of biological molecules. Based on such analyses, the promising natural aptamer sequences are 7/8 (42 nt), 17/18/19/20 (29 nt), 31 (23 nt) and 32 (19 nt). Further support for these candidates is provided by their sequence conservation. Candidate aptamers 7 and 8 are identical 42 nt non-coding sequences found in plasmids pNRC200 and pNRC100, respectively, of *Halobacterium* sp. Most interestingly, the 39 nt sequences 17--20 are identical copies found in hypothetical genes (yciQ, ECs1849, Z2542) of four different *E.coli* species. It is unlikely that candidate sequences 7/8 and 17/18/19/20 occur by chance. [Table 3](#tbl3){ref-type="table"} shows that several other mostly shorter sequences (2--3, 13--15, 21--24, 25--27, 28--30, 33--34, 35--36) also exist in multiple copies. However, candidate sequences 31 and 32 exist as unique sequences in *E.coli* genomes; sequence 31 occurs in the non-coding region and sequence 32 in gene Smf.

Thus, sequences 7/8 (ATP) and 17/18/19/20 (neomycin B) are promising candidates for natural aptamers based on energetic and statistical tests, and sequence conservation; sequences 31 (neomycin B) and 32 (neomycin B) are judged to be good candidates based on energetic and statistical tests. These final sequences 7/8, 17/18/19/20, 31 and 32 ([Table 3](#tbl3){ref-type="table"}) comprise our best candidates for experimental testing. The functions of these candidate aptamers could be verified by performing ligand-binding experiments *in vitro*, and their existence *in vivo* could be determined using standard gene expression assays.

SUMMARY AND CONCLUSION
======================

Our method for searching for artificial aptamer motifs in the genomes of various organisms includes a series of statistical, thermodynamic and biological (sequence conservation) tests to screen and produce the most promising candidates. In our application to ATP, chloramphenicol, neomycin B and streptomycin aptamers, we have found several promising natural aptamer motifs (sequences 7/8, 17/18/19/20, 31 and 32 in [Table 3](#tbl3){ref-type="table"}). These candidates, possessing characteristics of functional RNA molecules (stable folds and sequence conservation), are found in coding and non-coding regions of bacterial and archaeal genomes. Collaborations are underway to test these candidates in the laboratory.

Many algorithmic improvements can be envisioned so that our tool will provide a general resource to screen and discover aptamer motifs in genomes. Automating the analyses so that the algorithm can be applied to all genomes comprehensively as well as to the numerous aptamers catalogued in the Aptamer Database ([@b34]) is highly desirable. Better ways to eliminate false-positives from our search results are also needed. With experimental feedback, further computational and biological improvements can be made. The resulting computational tool in conjunction with *in vitro* technology has the potential to help the effort of expanding known RNA repertoire by identifying novel RNA genes or RNA-based regulatory mechanisms.
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![The hydrogen-bonding scheme of the streptomycin-binding aptamer from crystal structure \[adapted from ([@b32])\]. The dotted lines represent hydrogen bonds between the streptomycin molecule (center) and the nucleotides in the binding pocket. Information about binding specificity is critical for creating accurate aptamer motif descriptors.](gki911f1){#fig1}

![The four experimental aptamers (left side of each set), constructed motif descriptors (middle) and candidate natural aptamers (right). Regions with many N\'s are variable in length. The nucleic acid base symbols are defined as follows: *N* = any base; V = A, C, or G; S = C or G. We search the genomes for any sequence that fits the descriptor consensus (allowing for slight mismatches). The experimental papers associated with the aptamers are (**a**) ATP ([@b38]), (**b**) chloramphenicol ([@b41]), (**c**) neomycin B ([@b42],[@b43]) and (**d**) streptomycin ([@b37]).](gki911f2){#fig2}

![Expected number of matches versus the observed number of matches for 46 aptamer motif/genome pairs; the expected number is calculated using random sequences. Deviations from the diagonal line represent genomes with either an over or under-representation of the given motif.](gki911f3){#fig3}

![Free energy $\Delta G_{37}^{\text{o}}$ versus melting temperature *T*~m~ (left column) and free energy versus Valley index *V* (middle column) for four good candidate aptamers (diamond symbol; right column) and their 1000 randomly shuffled sequences. Points in the ellipses cover 90% of sequences. Sequence numbers refer to those in [Table 3](#tbl3){ref-type="table"}.](gki911f4){#fig4}

![Examples of good and poor conformational energy landscapes. The good landscape is represented by candidate sequence 32 (black filled circles, shaded) and the poor landscape by candidate sequence 33/34 (red, diamonds) for the neomycin B antibiotic. The good candidate sequence exhibits a sharp, steep slope while the poor candidate sequence has multiple low-energy minima. The optimal and suboptimal structures are generated using the Vienna RNA Package.](gki911f5){#fig5}

###### 

The number of matches to the antibiotic-binding aptamer descriptors in bacterial genomes ('Obs.') and the expected number of matches calculated using random sequences with uniformly distributed nucleotides ('Exp.')

  Genome (NCBI accession number)                 Size (Mb)   Chloramphenicol   Streptomycin   Neomycin B   Total Obs.               
  ---------------------------------------------- ----------- ----------------- -------------- ------------ ------------ ---- ------ ----
  *Streptomyces avermitilis* (NC_003155)         9.2         0                 3.1            2            0.7          6    19.8   8
  *Streptomyces coelicolor* (NC_003888)          8.8         0                 2.9            1            0.7          1    18.9   2
  *Escherichia coli K12* (U00096)                4.7         7                 1.6            1            0.4          11   10.1   19
  *Escherichia coli O157:H7* (BA000007)          5.6         7                 1.9            1            0.4          17   12.0   25
  *Escherichia coli O157:H7 EDL933* (AE005174)   5.6         7                 1.9            1            0.4          19   12.0   27
  *Escherichia coli CFT073* (AE014075)           5.3         7                 1.8            0            0.4          17   11.4   24
  *Neisseria meningitidis MC58* (AE002098)       2.3         1                 0.8            0            0.2          9    4.9    10
  *Neisseria meningitidis Z2491* (AL157959)      2.2         5                 0.7            0            0.2          9    4.7    14
  *Sinorhizobium meliloti* (AL591688)            3.7         1                 1.2            1            0.3          3    7.9    5
  *Chlamydia trachomatis* (NC_000117)            1.1         4                 0.4            0            0.1          1    2.4    5
  Total                                          39                            7                           93                139    

The motif matches are generated by the RNAMotif program without any filtering.

###### 

The number of matches to the antibiotic-binding aptamer descriptors in archaeal genomes ('Obs.') along with the expected number of matches calculated using random sequences with uniformly distributed nucleotides ('Exp.')

  Genome (NCBI accession number)                                Size (Mb)   ATP   
  ------------------------------------------------------------- ----------- ----- -----
  *Aeropyrum pernix* (NC_000854)                                1.7         6     1.6
  *Archaeoglobus fulgidis DSM 4304* (NC_000917)                 2.2         6     2.1
  *Halobacterium sp. NRC-1* (NC_002607, NC_002608, NC_001869)   2.6         4     2.5
  *Methanobacterium thermoautotrophicum str.* (NC_000916)       1.8         6     1.7
  *Methanococcus jannaschii* (NC_000909, NC_001732, NC_01733)   1.7         4     1.6
  *Methanopyrus kandleri AV19* (NC_003551)                      1.7         3     1.6
  *Methanosarcina acetivorans C2A* (NC_003552)                  5.8         12    5.5
  *Methanosarcina mazei Goe1* (NC_003901)                       4.1         5     3.9
  *Pyrobaculum aerophilum* (NC_003364)                          2.3         2     2.2
  *Pyrococcus abyssi* (NC_000868)                               1.8         3     1.7
  *Pyrococcus furiosus DSM 3638* (NC_003413)                    1.9         8     1.8
  *Pyrococcus horikoshii* (NC_000961)                           1.8         3     1.7
  *Sulfolobus solfataricus* (NC_002754)                         3.0         2     2.8
  *Sulfolobus tokodaii* (NC_003106)                             2.7         4     2.5
  *Thermoplasma acidophilum* (NC_002578)                        1.6         2     1.5
  *Thermoplasma volcanium* (NC_002689)                          1.6         2     1.5
  Total                                                         72                

No additional filtering is applied to the motif matches found by the RNAMotif program.

###### 

The candidate natural aptamer sequences that fold to the target structures

  Sequence          Genome                                                              Location                     Gene             $\Delta G_{37}^{\text{o}}$ (kcal/mol)   *T*~m~ (°C)   $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ test   V    $V - \Delta G_{37}^{\text{o}}$ test   
  ----------------- ------------------------------------------------------------------- ---------------------------- ---------------- --------------------------------------- ------------- ------------------------------------------------ ---- ------------------------------------- ----
  Chloramphenicol                                                                                                                                                                                                                                                                       
      1             `5′-TCAGAGCTGA AAAACTGGCC CCGGGTGCAG CTAAAAACTG A`                  E.coli K12                   1 172 203        Mfd                                     −11.90        78.0                                             −    1.09                                  −
      2             `5′-TCAGAGCTGA AAAACTGGCC CCGAGTGCAG CTAAAAACTG A`                  E.coli O157:H7               1 532 105        ECs1492                                                                                                                                           
      3                                                                                 E.coli O157:H7 EDL933        1 617 201        Mfd                                     −10.58        72.6                                             −    2.40                                  −
      4             `5′-GGGAAACGCA AAAATCAGGT ACAGGCAGAC GACGGTGGCG TAAAACTCCC`         N.meningitidis Z2491         2 179 300        Non-coding                              −9.17         54.4                                             −    5.28                                  −
      5             `5′-GCAACGGAAA AAGCTGCTTT GCCCTTGAAG GCGGGGGGTG ATTCGGAAAA TGC`     S.meliloti                   493 471          Non-coding                              −14.44        48.8                                             −    6.18                                  −
  Streptomycin                                                                                                                                                                                                                                                                          
      6             `5′-GTACCCGGAC GTGCCCTTCC AGGCGTCCAT GGAGGCCTGG CTCGGGGCGG TGC`     S.avermitilis                7 323 209        Non-coding                              −28.64        111.4                                            −    0.84                                  −
  ATP                                                                                                                                                                                                                                                                                   
      **7**         `5′-GCTGGTCGAA GACACTGGCT GTCGCTGTCG ACGGCGATCA GC`                 *Halobacterium* sp. *NRC1*   pNRC200 92 229   Non-coding                                                                                                                                        
      **8**                                                                             *Halobacterium* sp. *NRC1*   pNRC100 92 229   Non-coding                              −19.43        71.6                                             \+   4.54                                  \+
      9             `5′-TCTGTCCAAC CAGAGGAAAC TGGCTTCCAA AGTTCTCGGA TGCGGGCTTG ATAGG`   M.acetivorans C2A            1 295 025        MA1090                                  −16.04        71.2                                             −    6.40                                  −
      10            `5′-CAAGGGCTGA AGAAAATGCT GTGGTTATAT CCTACCAGGG TGACGGGGAC CTTG`    M.mazei Goe1                 3 868 884        vorA                                    −13.71        69.4                                             −    8.46                                  −
      11            `5′-CTTGCTTTGA AAAAACTGGC AAATTCAACA AGGATTGCGA AGTACG`             P.furiosus; DSM 3638         168 991          PF0158                                  −7.48         63.8                                             −    9.49                                  −
  Neomycin B                                                                                                                                                                                                                                                                            
      12            `5′-TGAGCAGGGG CGAGAAGTTT TTCCTTG`                                  E.coli K12                   3 430 475        smf_1                                   −5.37         67.2                                             −    8.23                                  −
      13                                                                                E.coli K12                   1 832 073        Non-coding                                                                                                                                        
      14            `5′-TGTGTCGGGC GTAGAGTTTT GCGAG`                                    E.coli O157:H7 EDL933        2 508 764        Non-coding                              −4.12         59.6                                             −    3.25                                  −
      15                                                                                E.coli CFT073                1 987 894        Non-coding                                                                                                                                        
      16            `5′-CTGCGGGGGA ACACTTTGGT G`                                        E.coli K12                   3 973 740        wecE                                    −3.54         60.0                                             −    4.27                                  −
      **17**        `5′-AGTCTGGTGG GCGATATGTT TATTATGAT`                                E.coli K12                   1 324 039        yciQ                                    −6.10         57.8                                             \+   2.24                                  −
      **18**                                                                            E.coli O157:H7               1 826 735        ECs1840                                                                                                                                           
      **19**                                                                            E.coli O157:H7 EDL933        2 260 441        Z2542                                                                                                                                             
      **20**                                                                            E.coli CFT073                1 569 619        yciQ                                                                                                                                              
      21                                                                                E.coli O157:H7               1 373 724        ECs1300                                                                                                                                           
      22            `5′-ATTCACTGGG CGACATGTTT GATGAAT`                                  E.coli O157:H7 EDL933        1 457 496        Z1560                                   −5.55         61.4                                             −    1.41                                  −
      23                                                                                E.coli O157:H7 EDL933        1 061 889        Z1121                                                                                                                                             
      24                                                                                E.coli CFT073                1 130 797        c1166                                                                                                                                             
      25                                                                                E.coli O157:H7               1 037 740        ECs0954                                                                                                                                           
      26            `5′-AATGGGCGCA GAGTTTGTT`                                           E.coli O157:H7 EDL933        1 039 400        Z1102                                   −3.65         60.8                                             −    1.33                                  −
      27                                                                                E.coli CFT073                960 757          c1001                                                                                                                                             
      28                                                                                E.coli O157:H7               3 148 310        Non-coding                                                                                                                                        
      29            `5′-CCAGCGGGCG CAGAGTTTAT GGG`                                      E.coli O157:H7 EDL933        3 218 265        Non-coding                              −4.98         57.4                                             −    0.42                                  −
      30                                                                                E.coli CFT073                2 704 642        Non-coding                                                                                                                                        
      **31**        `5′-TGCGGGCGAA CAGTTTGCA`                                           E.coli O157:H7 EDL933        5 503 670        Non-coding                              −7.61         81.0                                             \+   1.12                                  \+
      **32**        `5′-TTGAGCAGGG GCGTGAAGTT TTTGCTTTG`                                E.coli CFT073                3 864 206        Smf                                     −10.79        83.4                                             \+   1.44                                  \+
      33            `5′-TTCCTGAAGG GGGACGACTT TGATGGGGA`                                N.meningitidis MC58          1 221 920        Non-coding                              −7.44         65.2                                             −    8.29                                  −
      34                                                                                N.meningitidis Z2491         1 283 084        Non-coding                                                                                                                                        
      35            `5′-ACGAGGGCGG TAAGTTTTTT T`                                        N.meningitidis MC58          1 468 213        Non-coding                              −2.55         51.6                                             −    1.22                                  −
      36                                                                                N.meningitidis Z2491         1 553 595        Non-coding                                                                                                                                        
      37            `5′-GCAGGTGGGC GCAGAGTTTG CCATT`                                    C.trachtomatis               604 373          yjeE                                    −9.07         83.0                                             −    0.76                                  −

The physical properties, energetic test results, and location(s) of each candidate sequence are reported. $\Delta G_{37}^{\text{o}}$, *T*~m~, and *V* denote the free energy, melting temperature and Valley index, respectively. The $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ and $V - \Delta G_{37}^{\text{o}}$ test results (+ or −) at 90% confidence level are calculated using the thermodynamic scatter plots (see text and [Figure 4](#fig4){ref-type="fig"}). Location refers to the position of the start site of a candidate sequence (by nucleotide number) and Gene refers to the gene\'s name (GenBank annotations) or non-coding region containing the candidate sequence. The locations of sequences 7 and 8 are in the associated species\' plasmids. The most promising candidates are numbered in bold.

###### 

The expected frequency of each aptamer descriptor per 1 and 10 million base pairs of random sequence with uniformly distributed nucleotides

  Descriptor        Frequency ± 1 standard error   
  ----------------- ------------------------------ ---------------
  Chloramphenicol   0.3320 ± 0.0007                3.320 ± 0.007
  Streptomycin      0.0778 ± 0.0003                0.778 ± 0.003
  Neomycin B        2.1471 ± 0.0015                21.47 ± 0.015
  ATP               0.9424 ± 0.0009                9.424 ± 0.009

###### 

The nucleotide distribution of genomes

                                                 T(U) (%)   C (%)   A (%)   G (%)
  ---------------------------------------------- ---------- ------- ------- -------
  Streptomyces avermitilis                       14.6       35.4    14.7    35.3
  Streptomyces coelicolor                        14.0       36.0    13.9    36.1
  Escherichia coli K12                           24.6       25.4    24.6    25.4
  Escherichia coli O157:H7                       24.7       25.2    24.8    25.3
  Escherichia coli O157:H7 EDL933                24.7       25.2    24.8    25.2
  Escherichia coli CFT073                        24.7       25.3    24.8    25.2
  Neisseria meningitidis MC58                    24.3       25.6    24.2    26.0
  Neisseria meningitidis Z2491                   24.2       25.9    24.0    25.9
  Sinorhizobium meliloti                         18.6       31.5    18.6    31.2
  Chlamydia trachomatis                          29.3       20.6    29.4    20.7
  Aeropyrum pernix                               22.1       28.4    21.6    28.0
  Archaeoglobus fulgidis DSM 4304                25.6       24.2    25.8    24.4
  Halobacterium sp. NRC-1                        17.1       33.0    17.0    33.0
  Methanobacterium thermoautotrophicum str. ΔH   25.4       24.7    25.1    24.8
  Methanococcus jannaschii                       34.3       15.5    34.4    15.7
  Methanopyrus kandleri AV19                     19.4       30.7    19.5    30.4
  Methanosarcina acetivorans C2A                 28.8       21.4    28.5    21.3
  Methanosarcina mazei Goe1                      29.2       20.7    29.3    20.8
  Pyrobaculum aerophilum                         24.1       25.4    24.5    25.9
  Pyrococcus abyssi                              27.7       22.4    27.6    22.3
  Pyrococcus furiosus DSM 3638                   29.6       20.4    29.6    20.4
  Pyrococcus horikoshii                          29.1       21.2    29.0    20.7
  Sulfolobus solfataricus                        32.3       17.9    31.9    17.9
  Sulfolobus tokodaii                            33.8       16.3    33.4    16.5
  Thermoplasma acidophilum                       26.8       22.9    27.2    23.1
  Thermoplasma volcanium                         29.9       19.9    30.2    20.0

###### 

The physical properties and stability test results for five biological RNA sequences

  Sequences   RNA                                                                                                                                       NCBI accession   $\Delta G_{37}^{\text{o}}$ (kcal/mol)   *T*~m~ (°C)   $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ test   V    $V - \Delta G_{37}^{\text{o}}$ test   
  ----------- ----------------------------------------------------------------------------------------------------------------------------------------- ---------------- --------------------------------------- ------------- ------------------------------------------------ ---- ------------------------------------- ----
  B1          `5′-GGAUACGGCC AUACUGCGCA GAAAGCACCG CUUCCCAUCC GAACAGCGAA GUUAAGCUGC GCCAGGCGGU GUUAGUACUG GGGUGGGCGA CCACCCGGGA AUCCACCGUG CCGUAUCCU`   5S RNA           M34003                                  −61.78        93.6                                             \+   4.13                                  \+
  B2          `5′-GGUCCUAUGG UCUAGUGGUC AGGACAUUGG ACUCUGAAUC CAGUAACCCG AGUUCAAAUC UCGGUAGGAC CU`                                                      Gln tRNA                                                 −29.65        87.4                                             \+   2.65                                  \+
  B3          `5′-AGCACCGCCU GCUACUUACA UCGCAUUUAU CUUUCGCCUU UUACUAAAGA UAGCCGUGAG UGAGCAGGCA CUGCGGUGCA UUGACCCAAU UUUUGGAGCC CCCUCAAAAG GGCA`        U5 RNA           AF095839                                −42.96        86.8                                             \+   7.25                                  \+
  B4          `5′-UGCAGUUUGC UGCGCUAUUA GUUUGGAACA ACACUGAGAA GAUUAGCAUG GCCCCUGCGC AAGGACGGCA UCUUUCUUUG AGAGGUGUGC UGGGCUCGCC CAGCUUUU`               U6 RNA           AF053588                                −38.43        67.4                                             \+   18.06                                 −
  B5          `5′-GACGUGUUAC AGCUCUUUUA GAAUUUGUCU AGUAGGCUUU CUGGCUUUUC ACCGGAAAGC CCCU`                                                               U7 RNA           M17910                                  −19.45        93.4                                             \+   8.85                                  \+

$\Delta G_{37}^{\text{o}}$, *T*~m~ and *V* denote the free energy, melting temperature and Valley index, respectively. The $T_{\text{m}} - \Delta G_{37}^{\text{o}}$ and $V - \Delta G_{37}^{\text{o}}$ test results (+ or −) at 90% confidence level are calculated using the thermodynamic scatter plots (see text and [Figure 4](#fig4){ref-type="fig"}).

[^1]: Present address Uri Laserson, Department of Mathematics, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
